216 related articles for article (PubMed ID: 22866900)
21. Distinct Anti-IFI16 and Anti-GP2 Antibodies in Inflammatory Bowel Disease and Their Variation with Infliximab Therapy.
Caneparo V; Pastorelli L; Pisani LF; Bruni B; Prodam F; Boldorini R; Roggenbuck D; Vecchi M; Landolfo S; Gariglio M; De Andrea M
Inflamm Bowel Dis; 2016 Dec; 22(12):2977-2987. PubMed ID: 27636380
[TBL] [Abstract][Full Text] [Related]
22. Anti-Outer membrane protein C and anti-glycoprotein 2 antibodies in inflammatory bowel disease and their association with complicated forms of Crohn's disease.
Kohoutova D; Drahosova M; Moravkova P; Rejchrt S; Bures J
BMC Gastroenterol; 2014 Dec; 14():190. PubMed ID: 25551469
[TBL] [Abstract][Full Text] [Related]
23. Pancreatic autoantibodies are associated with reactivity to microbial antibodies, penetrating disease behavior, perianal disease, and extraintestinal manifestations, but not with NOD2/CARD15 or TLR4 genotype in a Hungarian IBD cohort.
Lakatos PL; Altorjay I; Szamosi T; Palatka K; Vitalis Z; Tumpek J; Sipka S; Udvardy M; Dinya T; Lakatos L; Kovacs A; Molnar T; Tulassay Z; Miheller P; Barta Z; Stocker W; Papp J; Veres G; Papp M;
Inflamm Bowel Dis; 2009 Mar; 15(3):365-74. PubMed ID: 18972554
[TBL] [Abstract][Full Text] [Related]
24. Crohn's disease-specific pancreatic autoantibodies are specifically present in ruminants with paratuberculosis: implications for the pathogenesis of the human disease.
Liaskos C; Spyrou V; Roggenbuck D; Athanasiou LV; Orfanidou T; Mavropoulos A; Reinhold D; Rigopoulou EI; Amiridis GS; Billinis C; Bogdanos DP
Autoimmunity; 2013 Sep; 46(6):388-94. PubMed ID: 23638886
[TBL] [Abstract][Full Text] [Related]
25. Pancreatic anti-GP2 and anti-Saccharomyces cerevisiae antibodies in ruminants with paratuberculosis: A better understanding of the immunopathogenesis of Crohn's disease.
Liaskos C; Gkoutzourelas A; Spyrou V; Koutsoumpas A; Athanasiou LV; Amiridis GS; Billinis C; Bogdanos DP
Clin Res Hepatol Gastroenterol; 2020 Oct; 44(5):778-785. PubMed ID: 32035824
[TBL] [Abstract][Full Text] [Related]
26. Anti-Saccharomyces cerevisiae antibody does not differentiate between Crohn's disease and intestinal tuberculosis.
Makharia GK; Sachdev V; Gupta R; Lal S; Pandey RM
Dig Dis Sci; 2007 Jan; 52(1):33-9. PubMed ID: 17160471
[TBL] [Abstract][Full Text] [Related]
27. Optimising the diagnostic value of anti-Saccharomyces cerevisiae-antibodies (ASCA) in Crohn's disease.
Klebl FH; Bataille F; Hofstädter F; Herfarth H; Schölmerich J; Rogler G
Int J Colorectal Dis; 2004 Jul; 19(4):319-24. PubMed ID: 14745572
[TBL] [Abstract][Full Text] [Related]
28. Anti-pancreatic antibody in Turkish patients with inflammatory bowel disease and first-degree relatives.
Demirsoy H; Ozdil K; Ersoy O; Kesici B; Karaca C; Alkim C; Akbayir N; Erdem LK; Onuk MD; Beyzadeoglu HT
World J Gastroenterol; 2010 Dec; 16(45):5732-8. PubMed ID: 21128324
[TBL] [Abstract][Full Text] [Related]
29. Phenotypic associations of Crohn's disease with antibodies to flagellins A4-Fla2 and Fla-X, ASCA, p-ANCA, PAB, and NOD2 mutations in a Swiss Cohort.
Schoepfer AM; Schaffer T; Mueller S; Flogerzi B; Vassella E; Seibold-Schmid B; Seibold F
Inflamm Bowel Dis; 2009 Sep; 15(9):1358-67. PubMed ID: 19253375
[TBL] [Abstract][Full Text] [Related]
30. Association of perinuclear antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies with Vienna classification subtypes of Crohn's disease.
Klebl FH; Bataille F; Bertea CR; Herfarth H; Hofstädter F; Schölmerich J; Rogler G
Inflamm Bowel Dis; 2003 Sep; 9(5):302-7. PubMed ID: 14555913
[TBL] [Abstract][Full Text] [Related]
31. A prospective comparative study of ASCA and pANCA in Chinese and Caucasian IBD patients.
Lawrance IC; Murray K; Hall A; Sung JJ; Leong R
Am J Gastroenterol; 2004 Nov; 99(11):2186-94. PubMed ID: 15555001
[TBL] [Abstract][Full Text] [Related]
32. Significance of serological markers in the disease course of ulcerative colitis in a prospective clinical cohort of patients.
Kovacs G; Sipeki N; Suga B; Tornai T; Fechner K; Norman GL; Shums Z; Antal-Szalmas P; Papp M
PLoS One; 2018; 13(3):e0194166. PubMed ID: 29590158
[TBL] [Abstract][Full Text] [Related]
33. Update on Anti-Saccharomyces cerevisiae antibodies, anti-nuclear associated anti-neutrophil antibodies and antibodies to exocrine pancreas detected by indirect immunofluorescence as biomarkers in chronic inflammatory bowel diseases: results of a multicenter study.
Desplat-Jégo S; Johanet C; Escande A; Goetz J; Fabien N; Olsson N; Ballot E; Sarles J; Baudon JJ; Grimaud JC; Veyrac M; Chamouard P; Humbel RL
World J Gastroenterol; 2007 Apr; 13(16):2312-8. PubMed ID: 17511029
[TBL] [Abstract][Full Text] [Related]
34. Glycoprotein 2 antibodies in Crohn's disease.
Roggenbuck D; Reinhold D; Werner L; Schierack P; Bogdanos DP; Conrad K
Adv Clin Chem; 2013; 60():187-208. PubMed ID: 23724745
[TBL] [Abstract][Full Text] [Related]
35. Levels of Anti-Citrullinated Protein Antibodies and Rheumatoid Factor, Including IgA Isotypes, and Articular Manifestations in Ulcerative Colitis and Crohn's Disease.
Janssen KMJ; Hop H; Vissink A; Dijkstra G; de Smit MJ; Brouwer E; Westra J
Int J Environ Res Public Health; 2020 Nov; 17(21):. PubMed ID: 33139618
[TBL] [Abstract][Full Text] [Related]
36. Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis.
Jendrek ST; Gotthardt D; Nitzsche T; Widmann L; Korf T; Michaels MA; Weiss KH; Liaskou E; Vesterhus M; Karlsen TH; Mindorf S; Schemmer P; Bär F; Teegen B; Schröder T; Ehlers M; Hammers CM; Komorowski L; Lehnert H; Fellermann K; Derer S; Hov JR; Sina C
Gut; 2017 Jan; 66(1):137-144. PubMed ID: 27406039
[TBL] [Abstract][Full Text] [Related]
37. Serological markers facilitate the diagnosis of Crohn's disease.
Gao X; Zhang Y
Postgrad Med; 2021 Apr; 133(3):286-290. PubMed ID: 33406965
[No Abstract] [Full Text] [Related]
38. Pancreatic autoantibodies and autoantibodies against goblet cells in pediatric patients with inflammatory bowel disease.
Kovacs M; Lakatos PL; Papp M; Jacobsen S; Nemes E; Polgar M; Solyom E; Bodi P; Horvath A; Muller KE; Molnar K; Szabo D; Cseh A; Dezsofi A; Arato A; Veres G
J Pediatr Gastroenterol Nutr; 2012 Oct; 55(4):429-35. PubMed ID: 22465933
[TBL] [Abstract][Full Text] [Related]
39. Loss and Gain of Tolerance to Pancreatic Glycoprotein 2 in Celiac Disease.
Laass MW; Röber N; Range U; Noß L; Roggenbuck D; Conrad K
PLoS One; 2015; 10(6):e0128104. PubMed ID: 26047356
[TBL] [Abstract][Full Text] [Related]
40. Anti-high mobility group box 1 and box 2 non-histone chromosomal proteins (HMGB1/HMGB2) antibodies and anti-Saccharomyces cerevisiae antibodies (ASCA): accuracy in differentially diagnosing UC and CD and correlation with inflammatory bowel disease phenotype.
Takaishi H; Kanai T; Nakazawa A; Sugata F; Nikai A; Yoshizawa S; Hamamoto Y; Funakoshi S; Yajima T; Iwao Y; Takemura M; Ozaki S; Hibi T
J Gastroenterol; 2012 Sep; 47(9):969-77. PubMed ID: 22644337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
